Kevin N. Dalby is an American pharmacist, who is currently the

Johnson & Johnson Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company i ...

Centennial Professor at University of Texas at Austin. He examine
fundamental mechanisms underlying human diseases
to develop new treatments while also teaching and motivating students to conduct research. Dalby is a member of several professional societies, including th
American Society for Biochemistry and Molecular Biology
th

and th
American Association for Cancer Research
In service to the country, Dalby serves on th
National Institute of Health's study sections
and is a peer reviewer for many leading journals. Dalby's primary research goal is to discover and characterize fundamental mechanisms that regulate molecular signaling in cancer. As th
Johnson & Johnson Centennial Professor of Chemical Biology & Medicinal Chemistry
he leads a team that uses a wide array of chemical, biochemical, biophysical, and physiological experiments to study phenomena o
signal transduction
His laboratory seeks to discove
new cell signaling processes and develop new molecular tools to facilitate investigations
For 20 years, Dalby has led a laboratory that has studied protein kinase signaling, reporting several foundational studies about mechanisms of protein kinase regulation, substrate specificity, and inhibition in that time.

References

Year of birth missing (living people) Living people University of Texas at Austin faculty American pharmacists {{US-med-bio-stub